Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer - Related Studies

Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

This study is ongoing, but not recruiting participants.

Study NCT00004100. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Lung Cancer

2	Additional conditions recognized in this trial
		Carcinoma, Non-Small-Cell Lung
		Lung Neoplasms

3	More general conditions related to this trial
		Carcinoma
		Lung Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms
		Thoracic Neoplasms

4	Interventions listed in this trial
		cisplatin
		gemcitabine hydrochloride
		vinorelbine ditartrate

5	Additional drug interventions recognized in this trial
		Gemcitabine
		Vinblastine
		Vinorelbine

6	More general drug interventions related to this trial
		Anti-Infective Agents
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antimitotic Agents
		Antineoplastic Agents
		Antineoplastic Agents, Phytogenic
		Antiviral Agents
		Enzyme Inhibitors
		Immunologic Factors
		Immunosuppressive Agents
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Radiation-Sensitizing Agents
		Therapeutic Uses
		Tubulin Modulators

7	Sponsors listed in this trial
		Istituto Nazionale per lo Studio e la Cura dei Tumori
		National Cancer Institute of Canada